Trial intelligence / Profile preview

Propolis for Periodontitis and Type 2 Diabetes

NCT02794506Phase 4Completed

Start
Jun 2014
Primary completion
Dec 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in type 2 diabetes mellitus (T2DM) and chronic periodontitis comparing Propolis + SRP with Placebo + SRP (2 arms). Primary endpoint: Change of glycosylated hemoglobin at 6 months. Started Jun 2014; status: completed.

02

Drugs

BioPropolis
03

Conditions

type 2 diabetes mellitus (T2DM)chronic periodontitis

Beyond the preview

Go deeper on NCT02794506.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02794506.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call